Search Funding Opportunities

Search by category

Pfizer: Global Awards for Advancing Chronic Pain Research

Grant Amount: Up to $150,000
Deadline: September 22, 2021
Category: Pain management; osteoarthritis,
Additional Information

Grants of up to $150,000 will be awarded in support of innovative, novel research proposals that aim to advance the understanding and management of chronic pain due to osteoarthritis (OA).

Pfizer Inc. has announced a call for proposals for its fourth Global Awards for Advancing Chronic Pain Research (ADVANCE) competitive grants program.

The program is looking for studies that aim to advance: the evaluation of unmet medical needs in pain management associated with OA — including benefit-risk assessment and patient preference in the choice of pain medication for patients with comorbid conditions (e.g., cardiovascular disease or history of substance abuse); understanding how risks associated with long-term use of analgesics are assessed currently; treatment of chronic pain in special populations (e.g., postsurgical, elderly); evaluation of multi-disciplinary approaches to OA management (e.g., physical therapy, cognitive behavioral therapy [CBT]) and their combination with pharmacological treatment; understanding and predicting response to treatment, disease state, and course of OA (normal and rapid trajectories); approaches to improving adherence to therapy or therapeutic regimes for pain associated with OA; the use of patient characteristics such as biomarkers or other objective evaluations (e.g., quantitative sensory testing [QST], imaging modalities) in the assessment and management of OA to better understand disease course; and evaluation of improved function — such as how changes of physical function are assessed in clinical practice in patients with OA, and how current physical function assessment could be improved; how individual goal setting can contribute to treatment outcome (including pain and function); and what impact the improved physical function has on the patients’ quality of life.

The Principal Investigator must hold a doctoral degree (MD, PhD, PharmD, or equivalent). Investigators must be affiliated with an academic or medical institution.

Please contact Daniel Hadley if you are interested in applying to this opportunity.

Learn More